Sputnik V impact on Panacea Biotec
The production of Sputnik V, the COVID-19 vaccine granted emergency use authorisation, has been launched in India, said a joint statement issued by Russian Direct Investment Fund (RDIF) and pharmaceutical firm Panacea Biotec on May 24
I have came across this Ascending triangle, waiting for breakout !
I have came across this Ascending triangle, waiting for breakout !
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.